2008 Growth Company of the Year (Life Science)

2008 Growth Company of the Year (Life Science)

Serenex, Inc.

Serenex, Inc. is an integrated drug discovery and development company committed to improving the lives of patients by developing best-in-class therapeutic products. Their most advanced clinical product, SNX-5422, is a novel, orally bioavailable, small molecule inhibitor of Heat Shock Protein 90 (Hsp90). SNX-5542 is currently in phase 1 in cancer patients. Serenex was acquired by Pfizer in the first quarter of 2008.

What Members are Saying

"CED is a premiere catalyst for networking and access. CED offers one of the best available common grounds for bringing entrepreneurs of all backgrounds together." - Clay Dunnagan, VP of Business Development, Vital Source Technologies (also a FastTrac Tech instructor)